Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
600056 China Meheco Group
- 12.35
- +0.30+2.49%
Not Open Dec 12 15:00 CST
18.47BMarket Cap20.51P/E (TTM)
12.40High11.96Low436.62KlotVolume12.06Open12.05Pre Close535.42MTurnover2.92%Turnover Ratio17.62P/E (Static)1.50BShares13.8852wk High1.58P/B18.47BFloat Cap9.4552wk Low13.26Limit Up1.50BShs Float31.11Historical High10.85Limit Down3.65%Amplitude-1.82Historical Low0.23Dividend TTM12.26Avg Price183.36KlotAsk1.88%Div YieldTTM100Lot Size241.10KlotBid
China Meheco Group News
China Pharmaceutical: 2024 Fifth Extraordinary General Meeting of Shareholders Meeting Information
Announcement on the subsidiary obtaining approval for drug registration
2024 Fifth Extraordinary General Meeting of Shareholders Meeting Materials
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
Announcement on the progress of important shareholding companies planning to change the actual controller
Notice on convening the 5th Extraordinary General Meeting of Shareholders in 2024
Announcement on the subsidiary obtaining approval for drug registration
Announcement on the subsidiary obtaining approval for drug registration
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
Announcement on the resignation of a director
Legal Opinion on the 2024 Fourth Extraordinary General Meeting of Shareholders of China Pharmaceutical and Health Industry Co., Ltd.
Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders
China Pharmaceutical: 2024 Fourth Extraordinary General Meeting of Shareholders Meeting Information
2024 Fourth Extraordinary General Meeting of Shareholders Meeting Materials
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
Board Strategy and ESG Committee Implementation Rules (2024 Revision)
Announcement on the progress of participation in the establishment of the Life and Health Industry Fund and changes in the investment structure
Notice on Convening the Fourth Extraordinary General Meeting of Shareholders in 2024
